About Us

“To conquer cancer requires targeted therapies that are as genetically sophisticated and deadly as the cancer itself. In my opinion, there are no agents that have more potential than rationally-designed oncolytic virus therapies.”

Clodagh O’Shea, Ph.D.

Scientific Founder

Board Members, Founders and Advisors with decades of biotech and oncology innovation expertise

Board of Directors

Scientific Advisory Board

Strategic Advisors